Literature DB >> 25486462

A natural compound Evo(kes) signaling for fat regulation.

Hitoshi Yamashita1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25486462      PMCID: PMC4613549          DOI: 10.4161/15384101.2014.954213

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

Review 1.  mTOR: from growth signal integration to cancer, diabetes and ageing.

Authors:  Roberto Zoncu; Alejo Efeyan; David M Sabatini
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12-15       Impact factor: 94.444

Review 2.  mTOR is a key modulator of ageing and age-related disease.

Authors:  Simon C Johnson; Peter S Rabinovitch; Matt Kaeberlein
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

3.  Evodiamine improves diet-induced obesity in a uncoupling protein-1-independent manner: involvement of antiadipogenic mechanism and extracellularly regulated kinase/mitogen-activated protein kinase signaling.

Authors:  Ting Wang; Youxue Wang; Yasuhide Kontani; Yoshinori Kobayashi; Yuzo Sato; Nozomu Mori; Hitoshi Yamashita
Journal:  Endocrinology       Date:  2007-09-20       Impact factor: 4.736

4.  Evodiamine inhibits adipogenesis via the EGFR-PKCalpha-ERK signaling pathway.

Authors:  Ting Wang; Youxue Wang; Hitoshi Yamashita
Journal:  FEBS Lett       Date:  2009-10-23       Impact factor: 4.124

5.  Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity.

Authors:  Sung Hee Um; Francesca Frigerio; Mitsuhiro Watanabe; Frédéric Picard; Manel Joaquin; Melanie Sticker; Stefano Fumagalli; Peter R Allegrini; Sara C Kozma; Johan Auwerx; George Thomas
Journal:  Nature       Date:  2004-08-11       Impact factor: 49.962

6.  Evodiamine inhibits insulin-stimulated mTOR-S6K activation and IRS1 serine phosphorylation in adipocytes and improves glucose tolerance in obese/diabetic mice.

Authors:  Ting Wang; Tatsuya Kusudo; Tamaki Takeuchi; Yukari Yamashita; Yasuhide Kontani; Yuko Okamatsu; Masayuki Saito; Nozomu Mori; Hitoshi Yamashita
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.